ALS Stem Cell Treatment Breakthrough By Dr. David Greene Arizona
Through 17 years of experience, Dr David Greene Arizona is more than a ray of hope and light at the end of the tunnel for thousands of ALS (Amyotrophic lateral sclerosis) patients. This blog updates you with the most recent medical studies on utilizing stem cell therapy to treat ALS. Discover how this groundbreaking therapy can decelerate the deterioration of motor neurons and enhance the standard of living for individuals diagnosed with ALS.
All About ALS That You Need To Know
ALS, commonly known as Lou Gehrig’s disease, is a complex condition that challenges comprehension and treatment. It has an annual incidence rate of one to two cases per 100,000 individuals in the United States. Unknown factors account for around 95% of ALS cases, with only approximately 5% being hereditary. Despite the typical onset of ALS occurring between ages 50–60, it can develop in individuals of any age.
The onset of Amyotrophic Lateral Sclerosis (ALS) is characterized by the degeneration of neurons that regulate voluntary muscle control in the body. ALS impacts both upper and lower motor neurons, leading to the gradual weakening of muscles and the development of involuntary spasticity in affected individuals. These symptoms continue to worsen over time, exacerbating the effects of the disease. Dr. David Greene Arizona, advocates using stem cell therapy for better results of ALS treatment.
How Does R3 Stem Cell Therapy Work For ALS?
Mesenchymal stem cell therapy has demonstrated significant therapeutic potential across multiple clinical domains, with the ability to differentiate towards specific cell types or release additional growth and trophic factors. Clinical models indicate that mesenchymal stem cells (MSCs) could be a promising solution to treat ALS, as they can potentially delay the onset and progression of the disease, increasing lifespan and reducing motor neuron loss. Encouraging preclinical studies have prompted the use of MSCs in ALS patients.
What Are Researchers & Dr David Greene Arizona Take On Stem Cells Fight against ALS?
To test treatments, doctors require an adequate quantity of ALS sample cells. Luckily, Induced Pluripotent Stem Cells (IPSCs) can imitate the neurons impacted by ALS closely. Researchers can produce unlimited genetically similar IPSCs in the lab by utilising small skin samples from ALS patients. This ability benefits doctors worldwide, as they can continuously test various treatment options without causing additional harm to ALS patients.
Clinical trials are underway using stem cells as a natural treatment for ALS. One of the unique properties of stem cells is their ability to target damaged areas in the body and differentiate into different types of cells, including neurons. Stem cell transplants are being explored to safeguard the survival of healthy neurons and potentially regenerate new ones to replace the degenerated ones.
Takeaway
In conclusion, Dr David Greene Arizona, an orthopedic surgeon with 17 years of experience treating ALS patients with stem cell therapy, offers hope to those suffering from this complex condition. Stem cell therapy has shown significant potential in delaying the progression of ALS and improving patients’ quality of life. With ongoing research and clinical trials, stem cell therapy offers a promising solution to this challenging disease.
